Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RINGSIDE: AL102 in Progressing Desmoid Tumors
NCT04871282Phase 3Active, not recruiting
- Sponsor
- Immunome
- Start
- Sep 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of varegacestat in desmoid tumor, sponsored by Immunome. Started Sep 2021; status: active, not recruiting.
02
Drugs
varegacestat
03
Conditions
desmoid tumor
Beyond the preview
Go deeper on NCT04871282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871282.